- When drugs don't work and surgery is not possible, transplanting stem cells from the patient's own bone marrow is an effective alternative for the treatment of this chronic disease.
- The procedure has been tested successfully in the US and Italy, where total remission of the disease has been shown in 80% of cases, and considerable improvement in quality of life in the remaining 20% of cases. Since August 2008, Hospital Clnic has used this therapy in a total of 6 patients.
- In Spain, this disease affects 1% of the population between 18 and 40 years of age and each year approximately 2000 new cases are diagnosed. This regenerative therapy constitutes a new focus on the use of stem cells in intestinal diseases.
Barcelona, February 19, 2009. Cellular therapy with stem cells is revolutionizing the focus of treatment of many serious diseases. Replacing the cells of damaged tissue with other new cells from the same patient is already a reality. This is the basis of cellular therapy and regenerative medicine, the latest great advance in biomedicine. In this line, Hospital Clnic, Barcelona is leading the world in the application of an innovative cellular therapy that uses stem cells to treat Crohn's disease, a chronic genetic disease that affects 1% of the population in Spain and which has considerable impact on the quality of life of the patients. The procedure is based on an autologous bone-marrow transplant (when patients receive a transplant of their own stem cells) and now constitutes a treatment option to cure an intestinal disease that sometimes does not successfully respond to drugs and requires highly complex surgery that does not provide a cure.
Hospital Clnic, Barcelona is one of the few hospitals in the world to apply this new therapeutic option for patients with Crohn's disease, and it does so with the guarantee of success experienced in the US and Italy, where the technique has been tested with excell
'/>"/>
Page: 1 2 3 4 5 Related medicine news :1.
A potential molecular target for biotherapy esophageal squamous cell carcinomas2.
What is the most effective therapy for low-dose aspirin induced peptic ulcer?3.
Varian Medical Systems Has Received CE Mark for Proton Therapy System4.
Dr. Larry Kaskel, Medical Director of the Heart Attack Prevention Center, to Speak March 4th at CardioCareLive about FirstLine Therapy5.
Apple's iPod Touch Joins the iPhone as a Stuttering Therapy Tool At Hollins Communications Research Institute6.
Supplement of probiotics provides a new therapy for ulcerative colitis7.
An adjuvant chemotherapeutic agent in gastric cancer therapy8.
MU researcher demonstrates non-traditional therapy is effective as pain management9.
Public Cancer Center Becomes First in South-East Asia to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems10.
Lung Cancer Microscopic Appearance Affects Response to Chemotherapy11.
Gene Therapy Holds Promise for HIV